• Info
  • Significant Ownership

Significant Ownership of Soleus Capital Master Fund, L.P.

Signature - Title
/s/ Guy Levy - Guy Levy/Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Soleus Capital Master Fund, L.P..

Notify me when Soleus Capital Master Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Soleus Capital Master Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
THTX THERATECHNOLOGIES INC. Common Stock 10.4% $9.31M 4.8M SOLEUS CAPITAL MASTER FUND, L.P. 11 Apr 2025
JSPR JASPER THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 9.96% $5.41M 1.49M Soleus Capital Management, L.P. 31 Dec 2024
ORGO ORGANOGENESIS HOLDINGS INC. Common Stock, $0.0001 par value per share 9.9% $53.2M 12.5M Soleus Capital Master Fund, L.P. 31 Dec 2024
CELC CELCUITY INC. Common Stock 9.9% $31.8M 3.87M Soleus Capital Master Fund, L.P. 31 Dec 2024
EPIX ESSA PHARMA, INC. Common Stock 9.8% $7.28M $3.51M 4.36M +92.8% SOLEUS CAPITAL MASTER FUND, L.P. 17 Jul 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9.6% $18.7M 8.14M Soleus Capital Master Fund, L.P. 31 Dec 2024
NVCR NOVOCURE LIMITED Ordinary Shares, no par value per share 8.6% $125M $35.4M 9.64M +39.7% Soleus Capital Master Fund, L.P. 30 Sep 2025
VSTM VERASTEM, INC. Common Stock 7.3% $15.5M 3.35M Soleus Capital Management, L.P. 31 Dec 2024
NPCE NEUROPACE, INC. Common Stock, par value $0.001 per share 7% $28.9M 2.3M Soleus Capital Management, L.P. 30 Jun 2025
URGN UROGEN PHARMA LTD. Ordinary Shares, par value NIS 0.01 per share 4.7% $22.2M -$1.42M 2.19M -6.02% Soleus Capital Master Fund, L.P. 30 Jun 2025
PRAX PRAXIS PRECISION MEDICINES, INC. Common Stock, $0.0001 par value per share 4.6% $37.7M -$1.99M 967K -5.01% Soleus Capital Master Fund, L.P. 30 Jun 2025
AXGN AXOGEN, INC. Common Stock, $0.01 par value per share 3.7% $23.5M 1.45M Soleus Capital Master Fund, L.P. 31 Mar 2025
RIGL RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share 3.7% $12.5M -$9.01M 658K -41.8% Soleus Capital Master Fund, L.P. 30 Jun 2025
STAA STAAR SURGICAL COMPANY Common Stock, $0.01 par value per share 1% $13.4M -$55.4M 500K -80.5% Soleus Capital Master Fund, L.P. 30 Sep 2025
MURA Mural Oncology plc Ordinary Shares, nominal value $0.01 per share 0% $0 -$2.74M 0 -100% Soleus Capital Master Fund, L.P. 30 Sep 2025
SRDX SURMODICS, INC. Common Stock, $0.05 par value per share 0% $0 -$22.1M 0 -100% Soleus Capital Master Fund, L.P. 30 Sep 2025

Schedules 13D/G Reported by Soleus Capital Master Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.